Vimarsana
Biggest News Aggregation in the World

Trials Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Inc Today - Breaking & Trending Today

Oncology Pharma Inc.: Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development - Vimarsana News

Oncology Pharma Inc.: Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

SAN FRANCISCO, CA / ACCESSWIRE / May 9, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to execute its next phase with Connect2Trials, Inc. Originally, the

Oncology Pharma Inc.: Oncology Pharma Reports on Progress with Ribera Solutions - Vimarsana News

Oncology Pharma Inc.: Oncology Pharma Reports on Progress with Ribera Solutions

SAN FRANCISCO, CA / ACCESSWIRE / March 2, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc. ("The Company") is pleased to announce progress with its investment with Ribera Solutions'

FACIT welcomes life sciences executive Ken Newport to its Board; Director Shana Kelley appointed to the Order of Ontario - Vimarsana News

FACIT welcomes life sciences executive Ken Newport to its Board; Director Shana Kelley appointed to the Order of Ontario

FACIT welcomes life sciences executive Ken Newport to its Board; Director Shana Kelley appointed to the Order of Ontario News provided by Share this article Share this article Blend of scientific, industry, investment and entrepreneurial expertise complements FACIT's leading role in growing Ontario's life sciences commercialization TORONTO, Jan. 26, 2021 /PRNewswire/ - The Board of Directors of FACIT, a commercialization venture firm for Ontario cancer innovations, is pleased to report on the addition of Mr. Ken Newport, in the role of Director. Mr. Newport is a passionate executive and advo...